Evident Vascular secures funding to advance AI intravascular ultrasound technology, aiming for FDA clearance.

Evident Vascular, a San Jose-based medical tech company, secured undisclosed Series B funding to advance its AI-powered intravascular ultrasound (IVUS) technology. The funds will help develop the platform, which aims to improve vascular imaging and patient outcomes, and support FDA clearance for US market entry. Investors include Shangbay Capital, Vensana Capital, and two unnamed multinational backers.